• Citer

An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics.

par Johnson, Jeremy R;Lossignol, Dominique ;Burnell-Nugent, Mary;Fallon, Marie T
Référence Journal of pain and symptom management
Publication Publié, 2012-11

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	An Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics.
Auteur:	Johnson, Jeremy R; Lossignol, Dominique; Burnell-Nugent, Mary; Fallon, Marie T
Informations sur la publication:	Journal of pain and symptom management
Statut de publication:	Publié, 2012-11
Sujet CREF:	Cancérologie
MeSH keywords:	Administration, Oral
	Aerosols -- administration & dosage -- adverse effects
	Analgesics, Non-Narcotic -- administration & dosage -- adverse effects
	Analgesics, Opioid -- adverse effects -- therapeutic use
	Belgium -- epidemiology
	Dose-Response Relationship, Drug
	Dronabinol -- administration & dosage -- adverse effects
	Drug Tolerance
	Female
	Follow-Up Studies
	Great Britain -- epidemiology
	Humans
	Longitudinal Studies
	Male
	Middle Aged
	Neoplasms -- complications -- diagnosis -- nursing
	Pain Measurement -- drug effects
	Pain, Intractable -- diagnosis -- drug therapy -- etiology
	Palliative Care -- methods
	Terminal Care -- methods
	Treatment Failure
	Treatment Outcome
Note générale:	JOURNAL ARTICLE
Langue:	Autre
Identificateurs:	urn:issn:0885-3924
	info:doi/10.1016/j.jpainsymman.2012.07.014
	info:pii/S0885-3924(12)00439-3
	info:pmid/23141881